funder-graph

funder-graph › Recipients

Who funds Fox Chase Chemical Diversity Center Inc

EIN 26-3652213

Fox Chase Chemical Diversity Center Inc (EIN 26-3652213) was named as a grant recipient by 3 funders in 12 grants paid totaling $1,045,310 in tax years 2019–2025, as reported on the funders' Forms 990-PF and 990 Schedule I. Each edge was resolved to this EIN at the match tier shown. Dataset version 2026.09.0, built 2026-09-03.

Grants received

$1,045,310

12 grants paid

Funders

3

distinct grantmakers

Tax years

2019–2025

as reported by funders

Funders

Grantmakers ranked by total paid to Fox Chase Chemical Diversity Center Inc
FunderStateMatchGrantsTotal paidLatest year
Neurodegenerative Disease Researchinc 85-0520661FLA4$556,7802023
Thomas Jefferson University 23-1352651PAA1$264,6472025
Temple University - of the Commonwealth System of Higher Education 23-1365971PAA7$223,8832025

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Grants

The 12 most recent grants naming this organization.

Grants to Fox Chase Chemical Diversity Center Inc as reported by funders
Tax yearFunderRecipientMatchAmountTypePurposeSource filing
2025Thomas Jefferson UniversityFox Chase Chemical Diversity Ctr Inc Doylestown, PAA$264,647paidPROGRAM SUPPORT202631349349301748
2025Temple University - of the Commonwealth System of Higher EducationFox Chase Chemical Diversity Center Inc Doylestown, PAA$25,999paidResearch subcontract202631359349316148
2024Temple University - of the Commonwealth System of Higher EducationFox Chase Chemical Diversity Center Inc Doylestown, PAA$40,076paidResearch subcontract202521349349309422
2023Temple University - of the Commonwealth System of Higher EducationFox Chase Chemical Diversity Center Inc Doylestown, PAA$60,743paidResearch subcontract202401359349304330
2023Neurodegenerative Disease ResearchincFox Chase Doylestown, PAA$0paidMedical Research202432499349300803
2022Neurodegenerative Disease ResearchincFox Chase Doylestown, PAA$86,700paidMedical Research202310879349301326
2022Temple University - of the Commonwealth System of Higher EducationFox Chase Chemical Diversity Center Inc Doylestown, PAA$18,880paidResearch subcontract202341329349301939
2021Neurodegenerative Disease Research IncFox Chase Doylestown, PAA$310,080paidmedical research202200989349300145
2021Temple University - of the Commonwealth System of Higher EducationFox Chase Chemical Diversity Center Inc Doylestown, PAA$13,623paidResearch subcontract202201339349304695
2020Neurodegenerative Disease Research IncFox Chase Doylestown, PAA$160,000paidmedical research202122399349300337
2020Temple University - of the Commonwealth System of Higher EducationFox Chase Chemical Diversity Center Inc Doylestown, PAA$54,107paidResearch subcontract202141339349302439
2019Temple University - of the Commonwealth System of Higher EducationFox Chase Chemical Diversity Center Inc Doylestown, PAA$10,455paidResearch subcontract202011369349302556

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are inferred and should be read as leads until the check is published on the methodology page.

Derived from IRS Form 990-PF and Form 990 Schedule I e-file XML filed by the funders shown; this organization's identity from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The rows as Parquet: manifest.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.